Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis

Abstract

These results indicate that a low dose of NM can inhibit the colonic mucosal inflammation induced by TNBS in rats, which suggests that anti-tryptase therapy using low doses of NM has excellent potential to become a new therapeutic strategy for IBD.